|4Aug 11, 9:04 PM ET

Atkisson Erik 4

4 · Rain Oncology Inc. · Filed Aug 11, 2023

Insider Transaction Report

Form 4
Period: 2023-08-09
Atkisson Erik
General Counsel and CCO
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-08-09+60,25160,251 total
    Exercise: $1.21Exp: 2033-08-09Common Stock (60,251 underlying)
Footnotes (1)
  • [F1]This option represents a right to purchase a total of 60,251 shares of the Issuer's common stock, one half of which will vest on May 9, 2024, with the remaining one half vesting in full on February 9, 2025, subject to the Reporting Person's continued service to the Issuer.

Documents

1 file
  • 4
    tm2323614-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT